Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Theravance Bio Ord (TBPH)

Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Theravance Bio: Q4 Earnings Snapshot AP - Mon Feb 26, 3:39PM CST

Theravance Bio: Q4 Earnings Snapshot

TBPH : 9.52 (-1.75%)
Theravance Bio: Q3 Earnings Snapshot AP - Tue Nov 7, 2023

Theravance Bio: Q3 Earnings Snapshot

TBPH : 9.52 (-1.75%)
Theravance Biopharma to Report Third Quarter 2023 Financial Results on November 7, 2023 PR Newswire - Thu Oct 19, 2023

/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its third quarter 2023 financial results and provide a business update after market close...

TBPH : 9.52 (-1.75%)
Theravance Biopharma to Participate in an Upcoming Investor Conference PR Newswire - Tue Aug 29, 2023

/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference...

TBPH : 9.52 (-1.75%)
Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson's Disease and Movement Disorders PR Newswire - Mon Aug 28, 2023

/PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced new ampreloxetine data in neurogenic...

TBPH : 9.52 (-1.75%)
Theravance Bio: Q2 Earnings Snapshot AP - Mon Aug 7, 2023

Theravance Bio: Q2 Earnings Snapshot

TBPH : 9.52 (-1.75%)
Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update PR Newswire - Mon Aug 7, 2023

Q2 2023 YUPELRI® (revefenacin) net sales of $55.0 million, recognized by Viatris, up 12% from Q2 20221 Q2 2023 YUPELRI total retail TRx and new to product TRx...

TBPH : 9.52 (-1.75%)
Theravance Biopharma to Report Second Quarter 2023 Financial Results on August 7, 2023 PR Newswire - Mon Jul 24, 2023

/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its second quarter 2023 financial results and provide a business update after market...

TBPH : 9.52 (-1.75%)
Theravance Biopharma, Inc. Announces Orphan Drug Designation Granted to Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy PR Newswire - Tue May 9, 2023

/PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that the US Food and Drug Administration...

TBPH : 9.52 (-1.75%)
Theravance's (TBPH) Q1 Earnings and Revenues Miss Estimates Zacks - Tue May 9, 2023

Thervance's (TBPH) first-quarter 2023 loss wider than expected. Revenues decline year over year and also miss estimates.

TBPH : 9.52 (-1.75%)
ITRM : 1.4600 (+0.69%)
LRMR : 7.05 (-2.62%)
VTRS : 11.10 (-0.18%)

Barchart Exclusives

This Outperforming Dividend Aristocrat Could Rally Another 22%, Says Analyst Barchart - Wed Apr 17, 6:30PM CDT
With a track record of 30 years of dividend increases, this industrial stock is also delivering some outsized capital appreciation to shareholders lately. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot